NEWARK, Calif.–Bioengineering company ATUM announces today that it has extended its 2014 agreement with Archer Daniels Midland Company (NYSE: ADM) to apply ATUM’s proprietary bioengineering technology and gene engineering platform to ADM’s process technologies. “We are extremely excited to continue working with global leader ADM,” said Claes Gustafsson, ATUM Chief Commercial Officer. “Our proprietary bioengineering […]

Simulations Plus announced today that it received an extension to its funded research collaboration with the FDA to develop the GastroPlus OCAT model. New functionality to mechanistic ocular absorption model in GastroPlus™ supports FDA’s future Innovation Initiative Simulations Plus, Inc. (Nasdaq:SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and […]

Enzootic and NRGene assemble the first high-quality female shrimp genome to enhance all-female shrimp breeding Tel Aviv, Hong Kong & St. Louis – Enzootic, an animal biotechnology and genetics company leading the all-female shrimp revolution, and NRGene, the world’s leading provider of genomic big data analysis, have completed the sequencing and assembly of the world’s first high- […]

Micromeritics Instruments and Malvern Panalytical have announced today a new collaborative sales partnership. This strategic relationship brings two highly respected, market leading instrument providers together to offer customers an extensive and effective combined solution approach for materials and particle characterization. In several key markets around the world, Micromeritics will serve as a non-exclusive distributor for […]

PORT WASHINGTON, NY: Pall Corporation, a global leader in filtration, separation and purification, has formed a strategic partnership with Celltheon Corporation, an experienced cell line and expression technology platform development company. This partnership aligns Pall Biotech equipment and consumables with the Celltheon SMART™ Expression Platform to deliver integrated manufacturing solutions for customers developing biotherapeutics. It is part of Pall’s strategic […]

BEIJING — On August 29, 2018, Mr. Joydeep Goswami, the President of Clinical NGS and Oncology Thermo Fisher Scientific (hereinafter referred to as Thermo Fisher), and Mr. Peter Vuong, the Director of Global Product Management, Clinical NGS division Thermo Fisher visited the Beijing headquarters of Genetron Health, conducted in-depth discussions on strategic cooperation in gene sequencing and reached consensuses with the management. As a leading […]

We have teamed up with Nebion, to make it easier for users to combine Qlucore Omics Explorer and Genevestigator. This is an excellent combination for investigating RNA-seq gene expression data. Qlucore Omics Explorer and Genevestigator provides users an end-to-end solution for gene expression analyses. The users will benefit from seeing both the details of their […]

· Partnership expands number of free extensions available through StarDrop · EnamineStore contains over 3.3 million screening compounds, and 7.8 million building blocks CAMBRIDGE AND KIEV, UKRAINE, UNITED KINGDOM – Optibrium™, a developer of software for drug discovery, today announced a collaboration with Enamine, a chemical research organisation and compound supplier. The collaboration provides StarDrop™ […]

Cooperative effort will ensure top quality plants for medical treatment Ness Ziona and Ruhama, Israel – Legalization of cannabis for diverse medical conditions requires top quality control of plant material production. One of the most important quality measurements is the cannabis strain authentication. Cannabis strains differ significantly in the profile of active ingredients, mostly cannabinoids […]

Development collaboration integrates Sartorius Stedim Biotech’s BIOSTAT® STR bioreactors and Repligen’s XCell™ ATF cell retention control technology Customers to benefit from simplified, scalable solutions for intensified cell culture Göttingen, Germany and Waltham, MA, USA — Sartorius Stedim Biotech (SSB) (Euronext: DIM), a leading international supplier for the biopharmaceutical industry, and Repligen Corporation (NASDAQ:RGEN), a global life sciences company focused […]